首页> 外文OA文献 >CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

【2h】

CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

机译：抗一线疾病修饰疗法的多发性硬化患者中以CD206为靶点的脂质体髓鞘碱性蛋白肽：一项首次在人类中进行概念验证的剂量递增研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study [J] . Alexey Belogurov, Konstantin Zakharov, Yakov Lomakin, Neurotherapeutics . 2016,第4期

机译：抗一线疾病修饰疗法的多发性硬化症患者中以CD206为靶点的脂质体髓鞘碱性蛋白肽：一项人类首次概念验证剂量递增研究
2. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. [J] . Vojdani A, Vojdani E, Cooper E Journal of Internal Medicine . 2003,第4期

机译：多发性硬化症患者的髓鞘碱性蛋白，髓鞘少突胶质细胞肽，α-β-晶状体蛋白，淋巴细胞活化和细胞因子产生的抗体。
3. A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein. [J] . Pender MP, Csurhes PA, Houghten RA, Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology . 1996,第1期

机译：对多发性硬化症患者产生的人T细胞系进行研究，并通过用髓磷脂碱性蛋白的肽刺激来进行对照。
4. T cell receptor altered peptide ligands of Myelin Basic Protein and Proteolipid Protein (Linear and Cyclic) can modulate immune responses in SJL/J mice: Bioactive peptides for Multiple Sclerosis [C] . Maria Katsara, Theodore Tselios, Spyros Deraos International Peptide Symposium . 2009

机译：T细胞受体改变髓鞘碱性蛋白质和蛋白质（线性和环状）的肽配体可以调节SJL / J小鼠中的免疫应答：用于多发性硬化的生物活性肽
5. Biophysical approaches for the determination of the effects of multiple sclerosis-like mutations on myelin basic protein. [D] . Bates, Ian Randolph. 2004

机译：用于确定多发性硬化样突变对髓鞘碱性蛋白的影响的生物物理方法。
6. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human Proof-of-Concept Dose-Escalation Study [O] . Alexey Belogurov Jr., Konstantin Zakharov, Yakov Lomakin, 2016

机译：抗一线疾病修饰疗法的多发性硬化患者中以CD206为靶点的脂质体髓鞘碱性蛋白肽：一项首次在人类中进行概念验证的剂量递增研究
7. A Study Of Human T-Cell Lines Generated From Multiple Sclerosis Patients And Controls By Stimulation With Peptides Of Myelin Basic Protein [O] . M. P. Pender, P. A. Csurhes, R. A. Houghten, 2014

机译：通过用髓鞘碱性蛋白肽刺激从多发性硬化患者和对照产生的人T细胞系的研究

CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

著录项

引文网络

相似文献

相关主题

期刊订阅